Cubist Systematic Strategies, LLC Precigen, Inc. Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $18,487 - $46,009	21,009 Added 59.85%	56,110 $59,000
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $44,578 - $79,328	35,101 New	35,101 $53,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $288,314 - $634,291	-250,708 Reduced 94.39%	14,892 $20,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $452,658 - $943,236	236,994 Added 828.48%	265,600 $560,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $268,234 - $417,928	-75,987 Reduced 72.65%	28,606 $106,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $162,354 - $213,110	32,536 Added 45.15%	104,593 $522,000
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $449,635 - $592,308	72,057 New	72,057 $470,000
Q1 2021 May 17, 2021	SELL	$6.74 - $10.95 $575,730 - $935,348	-85,420 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $39,168 - $110,299	-10,445 Reduced 10.9%	85,420 $871,000
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $178,332 - $315,902	50,952 Added 113.45%	95,865 $336,000
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $21,219 - $53,639	-9,824 Reduced 17.95%	44,913 $224,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $79,916 - $393,559	54,737 New	54,737 $186,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.